MNPR
Monopar Therapeutics · Healthcare · Market cap $485.6M
Insiders sold $4.1M net in the last 90 days ·5 sellers, 0 buyers· 5 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 5, 2026
Insider Buying
$105K
reported purchases (SEC code P)
Insider Selling
$4.4M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 20, 2026
STARR CHRISTOPHER M
Monopar Therapeutics (MNPR) has 23 SEC Form 4 filings (61 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 20, 2026.
Inside the rolling window, 7 insiders at Monopar Therapeutics reported 1 open-market purchase totaling $105K and 6 open-market sales totaling $4.4M. Insiders have net sold $4.1M over the trailing 6 months. The most recent open-market filing is a sale of 8,400 shares by Director STARR CHRISTOPHER M, dated Oct 1, 2026, worth $659K.
- Industry:Biotechnology
- CEO:Chandler D. Robinson
- Employees:22
- HQ:Wilmette, IL, US
- IPO:2019-12-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
STARR CHRISTOPHER MFirst filing | Director | Sale | 8,400 | $659K | Oct 5 | -7.6% | SEC ↗ |
Robinson ChandlerFirst filing | Chief Executive Officer | Sale | 29,056 | $2.6M | Sep 29 | -9.6% | SEC ↗ |
| Director | Sale | 4,090 | $456K | Aug 29 | -35.4% | SEC ↗ | |
| Director | Sale | 3,788 | $423K | Aug 28 | — | SEC ↗ | |
RIOUX PATRICEFirst filing | Acting Chief Medical Officer | Sale | 1 | $111 | Aug 27 | — | SEC ↗ |
Vu Quan AnhFirst filing | Chief Financial Officer | Purchase | 1,500 | $105K | Dec 29 | — | SEC ↗ |
KLAUSNER ARTHUR JFirst filing | Director | Sale | 5,121 | $344K | Dec 19 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does MNPR have?
Monopar Therapeutics (MNPR) has 23 SEC Form 4 filings (61 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 20, 2026.
When was the most recent SEC Form 4 filing for MNPR?
The most recent Form 4 filing for MNPR on Tracefour is dated Oct 20, 2026.
What is the net insider flow at MNPR over the last 6 months?
Over the trailing 180 days, insiders at MNPR have net sold $4.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MNPR in the current window?
Inside the rolling window, insiders at MNPR bought $105K and sold $4.4M based on SEC Form 4 filings.
Can I get alerts for MNPR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Monopar Therapeutics (MNPR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Monopar Therapeutics is in the Healthcare sector.